Regeneron Raheen George

Order byBest matchMost fresh

Regeneron To Buy 23andMe For $256M After Bankruptcy

Digest more

Regeneron Pharmaceuticals to buy 23andMe for $256M

Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million.

· 2d · on MSN

· 1d · on MSN

Pharmaceutical company Regeneron buying 23andMe for $256 million

Daily Voice on MSN · 1d

Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

The drugmaker said it will deploy the company’s trove of DNA to enhance its work developing medicine, while maintaining the direct-to-consumer tests that have been used by millions to discover their a...

· 2d

· 13h

Regeneron's 23andMe Steal - Smart Genetics Play That Won't Cure Near-Term Growth Pains

Putnam Daily Voice · 1d

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

MassDevice1d

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to close in Q3 2025

Healthcare Dive2d

Regeneron wins bid to buy 23andMe out of bankruptcy

Regeneron’s offer, which is still subject to court and regulatory approvals, is a bet it can do what 23andMe couldn’t and mine the troves of genetics data the testing firm collects to discover new drug targets.

2don MSN

23andMe sells gene-testing business to DNA drug maker Regeneron

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.

Yahoo Finance21d

Q1 2025 Regeneron Pharmaceuticals Inc Earnings Call

Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...